
News|Articles|September 1, 2003
Cardiovascular benefit of 'polypill' evaluated in BMJ
Three different drugs at half the standard dose are estimated to reduce the risk of stroke by 63% and ischemic heart disease (IHD) events by 46% for those aged 60 to 69 years, according to a study in BMJ. Another study published in the same issue recommends that those with known occlusive vascular disease and everyone aged 55 years or older take a "polypill," including the combination of blood pressure-lowering drugs, a statin, folic acid, and aspirin.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Quadruplet treatments for multiple myeloma are rising but access varies | ASH 2025
2
ACIP votes to end universal birth-dose for hepatitis B vaccine with updated guidance for parents and doctors
3
AstraZeneca’s Imfinzi gains landmark FDA approval for early gastric and gastroesophageal cancers
4
ACIP to vote on major hepatitis B vaccine update that could reshape the childhood vaccine schedule
5





















































